190 related articles for article (PubMed ID: 33044808)
1. An Allosteric Modulator of RNA Binding Targeting the N-Terminal Domain of TDP-43 Yields Neuroprotective Properties.
Mollasalehi N; Francois-Moutal L; Scott DD; Tello JA; Williams H; Mahoney B; Carlson JM; Dong Y; Li X; Miranda VG; Gokhale V; Wang W; Barmada SJ; Khanna M
ACS Chem Biol; 2020 Nov; 15(11):2854-2859. PubMed ID: 33044808
[TBL] [Abstract][Full Text] [Related]
2. Small Molecule Targeting TDP-43's RNA Recognition Motifs Reduces Locomotor Defects in a
François-Moutal L; Felemban R; Scott DD; Sayegh MR; Miranda VG; Perez-Miller S; Khanna R; Gokhale V; Zarnescu DC; Khanna M
ACS Chem Biol; 2019 Sep; 14(9):2006-2013. PubMed ID: 31241884
[TBL] [Abstract][Full Text] [Related]
3. Strategies in the design and development of (TAR) DNA-binding protein 43 (TDP-43) binding ligands.
Rao PPN; Shakeri A; Zhao Y; Calon F
Eur J Med Chem; 2021 Dec; 225():113753. PubMed ID: 34388383
[TBL] [Abstract][Full Text] [Related]
4. Point mutations in the N-terminal domain of transactive response DNA-binding protein 43 kDa (TDP-43) compromise its stability, dimerization, and functions.
Mompeán M; Romano V; Pantoja-Uceda D; Stuani C; Baralle FE; Buratti E; Laurents DV
J Biol Chem; 2017 Jul; 292(28):11992-12006. PubMed ID: 28566288
[TBL] [Abstract][Full Text] [Related]
5. NMR Fragment-Based Screening against Tandem RNA Recognition Motifs of TDP-43.
Nshogoza G; Liu Y; Gao J; Liu M; Moududee SA; Ma R; Li F; Zhang J; Wu J; Shi Y; Ruan K
Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31262091
[TBL] [Abstract][Full Text] [Related]
6. Requirements for stress granule recruitment of fused in sarcoma (FUS) and TAR DNA-binding protein of 43 kDa (TDP-43).
Bentmann E; Neumann M; Tahirovic S; Rodde R; Dormann D; Haass C
J Biol Chem; 2012 Jun; 287(27):23079-94. PubMed ID: 22563080
[TBL] [Abstract][Full Text] [Related]
7. RNA binding mediates neurotoxicity in the transgenic Drosophila model of TDP-43 proteinopathy.
Ihara R; Matsukawa K; Nagata Y; Kunugi H; Tsuji S; Chihara T; Kuranaga E; Miura M; Wakabayashi T; Hashimoto T; Iwatsubo T
Hum Mol Genet; 2013 Nov; 22(22):4474-84. PubMed ID: 23804749
[TBL] [Abstract][Full Text] [Related]
8. A novel Drosophila model of TDP-43 proteinopathies: N-terminal sequences combined with the Q/N domain induce protein functional loss and locomotion defects.
Langellotti S; Romano V; Romano G; Klima R; Feiguin F; Cragnaz L; Romano M; Baralle FE
Dis Model Mech; 2016 Jun; 9(6):659-69. PubMed ID: 27101846
[TBL] [Abstract][Full Text] [Related]
9. Zn
Preethi S; Bharathi V; Patel BK
Int J Biol Macromol; 2021 Apr; 176():186-200. PubMed ID: 33577819
[TBL] [Abstract][Full Text] [Related]
10. Mice deficient in the C-terminal domain of TAR DNA-binding protein 43 develop age-dependent motor dysfunction associated with impaired Notch1-Akt signaling pathway.
Nishino K; Watanabe S; Shijie J; Murata Y; Oiwa K; Komine O; Endo F; Tsuiji H; Abe M; Sakimura K; Mishra A; Yamanaka K
Acta Neuropathol Commun; 2019 Jul; 7(1):118. PubMed ID: 31345270
[TBL] [Abstract][Full Text] [Related]
11. A complex network of interdomain interactions underlies the conformational ensemble of monomeric TDP-43 and modulates its phase behavior.
Mohanty P; Rizuan A; Kim YC; Fawzi NL; Mittal J
Protein Sci; 2024 Feb; 33(2):e4891. PubMed ID: 38160320
[TBL] [Abstract][Full Text] [Related]
12. Molecular dissection of ALS-linked TDP-43 - involvement of the Gly-rich domain in interaction with G-quadruplex mRNA.
Ishiguro A; Kimura N; Noma T; Shimo-Kon R; Ishihama A; Kon T
FEBS Lett; 2020 Jul; 594(14):2254-2265. PubMed ID: 32337711
[TBL] [Abstract][Full Text] [Related]
13. The molecular link between inefficient GluA2 Q/R site-RNA editing and TDP-43 pathology in motor neurons of sporadic amyotrophic lateral sclerosis patients.
Yamashita T; Kwak S
Brain Res; 2014 Oct; 1584():28-38. PubMed ID: 24355598
[TBL] [Abstract][Full Text] [Related]
14. ATP is a cryptic binder of TDP-43 RRM domains to enhance stability and inhibit ALS/AD-associated fibrillation.
Dang M; Kang J; Lim L; Li Y; Wang L; Song J
Biochem Biophys Res Commun; 2020 Jan; 522(1):247-253. PubMed ID: 31759630
[TBL] [Abstract][Full Text] [Related]
15. The N-Terminal Domain of ALS-Linked TDP-43 Assembles without Misfolding.
Tsoi PS; Choi KJ; Leonard PG; Sizovs A; Moosa MM; MacKenzie KR; Ferreon JC; Ferreon ACM
Angew Chem Int Ed Engl; 2017 Oct; 56(41):12590-12593. PubMed ID: 28833982
[TBL] [Abstract][Full Text] [Related]
16. Motor neurons and glia exhibit specific individualized responses to TDP-43 expression in a Drosophila model of amyotrophic lateral sclerosis.
Estes PS; Daniel SG; McCallum AP; Boehringer AV; Sukhina AS; Zwick RA; Zarnescu DC
Dis Model Mech; 2013 May; 6(3):721-33. PubMed ID: 23471911
[TBL] [Abstract][Full Text] [Related]
17. Amyotrophic lateral sclerosis-associated proteins TDP-43 and FUS/TLS function in a common biochemical complex to co-regulate HDAC6 mRNA.
Kim SH; Shanware NP; Bowler MJ; Tibbetts RS
J Biol Chem; 2010 Oct; 285(44):34097-105. PubMed ID: 20720006
[TBL] [Abstract][Full Text] [Related]
18. The role of transactive response DNA-binding protein-43 in amyotrophic lateral sclerosis and frontotemporal dementia.
Mackenzie IR; Rademakers R
Curr Opin Neurol; 2008 Dec; 21(6):693-700. PubMed ID: 18989115
[TBL] [Abstract][Full Text] [Related]
19. Tethering-induced destabilization and ATP-binding for tandem RRM domains of ALS-causing TDP-43 and hnRNPA1.
Dang M; Li Y; Song J
Sci Rep; 2021 Jan; 11(1):1034. PubMed ID: 33441818
[TBL] [Abstract][Full Text] [Related]
20. TAR DNA-binding protein 43 (TDP-43) liquid-liquid phase separation is mediated by just a few aromatic residues.
Li HR; Chiang WC; Chou PC; Wang WJ; Huang JR
J Biol Chem; 2018 Apr; 293(16):6090-6098. PubMed ID: 29511089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
